Gamu Dave Innocent Pasi is a seasoned financial professional and writer, bringing a wealth of experience from his prior roles as a financial analyst and in investment research. With a strong background in analyzing financial statements, capital markets, and the macro-economy, Gamu has a proven track record of providing actionable trading ideas and well-researched investment recommendations. His insights have been featured in reputable publications such as The Axis business magazine and Investment Quarterly ...

Gamu Dave Innocent Pasi is a seasoned financial professional and writer, bringing a wealth of experience from his prior roles as a financial analyst and in investment research. With a strong background in analyzing financial statements, capital markets, and the macro-economy, Gamu has a proven track record of providing actionable trading ideas and well-researched investment recommendations. His insights have been featured in reputable publications such as The Axis business magazine and Investment Quarterly ...

Twist Bioscience Corporation (NASDAQ: TWST ) stock is enjoying a great month with double-digit gains. However, for the past 52-week range, the stock is trading on the lower end of that range. Within the next month, the company will be releasing its Q4 and FY2025 results. IGamu Dave Innocent Pasi is a seasoned financial professional and writer, bringing a wealth of experience from his prior roles as a financial analyst and in investment research. With a strong background in analyzing financial statements, ca ...

Third quarter and Nine-month 2025 results Pre-tax income1 up +4% Q3/Q3, driven by management fees and technology Sustained inflows over nine months and in Q3   Assets under management2 at a new record high of €2,317bn Net inflows +€67bn over nine months, of which +€15bn in Q3 +€57bn in medium-to-long-term assets3 (MLT) over nine monthsContribution from all major client segments and regions       Growth in pre-tax income   Third quarter: adjusted pre-tax income1 €445m, growth of +4% Q3/Q34 driven b ...

公司股价表现 - 过去52周内公司股票实现了三位数的涨幅 [1] 公司业务定位 - 公司是一家专注于罕见病领域的创新企业 [1] - 公司近期展现出快速增长和强劲势头 [1]

股票表现 - 杰龙公司股票交易价格非常接近其52周低点 [1] - 该股今年以来已出现两位数跌幅 [1] - 过去一个月该公司股价遭受了中等个位数百分比的损失 [1] 分析师背景 - 文章作者Gamu Dave Innocent Pasi是一位经验丰富的金融专业人士和作家 [1] - 作者拥有金融分析师和投资研究领域的先前职位经验 [1] - 作者持有投资与投资组合管理研究生高管证书以及银行与金融商学学士荣誉学位 [1]

公司股价表现 - Aurinia Pharmaceuticals (AUPH) 股票本月表现疲软 出现两位数百分比跌幅 [1] - 过去六个月股价录得强劲的两位数百分比涨幅 [1] - 当前股价下跌可能是获利了结的信号 [1] 分析师背景 - 文章作者Gamu Dave Innocent Pasi为资深金融专业人士 拥有财务分析和投资研究经验 [1] - 作者具备分析财务报表、资本市场和宏观经济的背景 [1] - 作者持有投资与组合管理研究生执行证书以及银行与金融商学学士荣誉学位 [1]

公司股价表现 - Aurinia Pharmaceuticals (AUPH) 股票本月表现疲软 出现两位数百分比跌幅 [1] - 过去六个月股价录得强劲的两位数百分比涨幅 本月下跌可能是获利了结的信号 [1] 分析师背景 - 文章作者Gamu Dave Innocent Pasi为资深金融专业人士 拥有财务分析师和投资研究经验 [1] - 作者持有投资与组合管理研究生执行证书以及银行与金融商学学士荣誉学位 [1] - 作者擅长分析财务报表、资本市场和宏观经济 具备定量和定性分析技能 [1]

公司股价表现 - Cardiff Oncology Inc (NASDAQ: CRDF) 股票年内经历了两位数中段的跌幅 [1] - 在第三季度2025年财报电话会议前的一个月内 股价出现个位数后段的上涨 [1]

Cardiff Oncology, Inc. (NASDAQ: CRDF ) stock is having a tough year after dropping by mid-double-digit losses. However, for the past month it has seen some late single-digit wins as we head towards its Q3 2025 earnings call, which IGamu Dave Innocent Pasi is a seasoned financial professional and writer, bringing a wealth of experience from his prior roles as a financial analyst and in investment research. With a strong background in analyzing financial statements, capital markets, and the macro-economy, Gam ...